Across the National Nuclear Security Administration’s sites and Washington headquarters, the trickle of current positive cases remained steady at under 200 this week, while the number of vaccines administered across the nuclear security enterprise continued to climb.
Due to revised Department of Energy guidelines, NNSA is only reporting confirmed active cases and any additional deaths, an agency spokesperson said. As of April 16, there had been 5,306 confirmed positive cases at the agency. Of those cases, 16 were fatal. Washington headquarters was tracking 162 positive cases of COVID-19 as of Friday, the spokesperson said. Those figures are flat compared to last week.
As of Friday, more than 2,200 personnel at Pantex and Y-12 — including DOE federal employees — had received one dose of a COVID-19 vaccine, the Consolidated Nuclear Security spokesperson wrote.
About 2,900 employees across the two sites had received a second dose at deadline, said the spokesperson, up about 300, compared with last week. Two of the three vaccines available in the U.S. require two doses.
Of those total doses, about 1,600 were administered at Pantex, flat compared with last week.
At the Y-12 National Security Complex in Tennessee, about 2,100 employees had received at least a dose at deadline. Y-12 started administering vaccines on-site March 31, the spokesperson said. The Y-12 figures account for vaccinations administered off-site before the complex was cleared to give out doses inside the fence.
Meanwhile, at the Nevada National Security Site, about 1,900 people had gotten at least one dose while 1,700 had received a second dose, a spokesperson said Thursday in an email. About 50% of people at the site were still teleworking.
National Laboratories Cases
Following are the reported numbers of confirmed COVID-19 cases at NNSA nuclear weapons laboratories, along with increases relative to the prior week and the number of people vaccinated, as provided Friday by the labs.
Lawrence Livermore National Laboratory:
Cases: 327 (+1)
At deadline Friday, Livermore had given out some 2,300 first doses of a COVID-19 vaccine, a spokesperson wrote in an email.
Livermore is a designated point of distribution for the vaccine in California and in March received its stockpile of doses from DOE and NNSA in collaboration with the Pentagon, the Livermore spokesperson has said.
Those doses administered so far covered “about one quarter of our population,” the lab spokesperson has said.
Los Alamos National Laboratory:
Cases: 828 (+6. 785 people who got sick had recovered, as of deadline). Los Alamos has started vaccinations, but a spokesperson declined to say how many personnel there had received doses.
Internal tests: 18,281 (+215. A lab spokesperson said Friday these on-site tests have resulted in 259 positive results: which was up by just one, compared with last week).
Teleworking: Roughly 60% of all employees, Flat compared with last week.
Sandia National Laboratories:
In March, Sandia National Laboratories instituted a one-week lag time reporting COVID data to the public because of “a shift in when our numbers are being updated internally,” a spokesperson said.
Here are the most recent numbers available for Sandia at deadline, which were current as of April 9.
Cases: 840 (+12).
Internal tests: 11,430 (+148).
Sandia started vaccinations the week of Jan. 11. Since then, a labs spokesperson said, 1,680 people had been fully vaccinated at Sandia’s New Mexico site through the onsite clinic, flat compared with the prior week.
Another 2,393 Sandia people had been fully vaccinated at offsite locations, up 523 from the prior week. At Sandia’s California site, 336 people had been fully vaccinated at offsite locations, up 112 from the prior week.
Sandia had knowledge of 4,409 fully vaccinated employees as of April 9, up 635 from the prior week.
Teleworking: Roughly 65% of all employees, flat compared with the prior week.
